A Radiological-Radiomics model for differentiation between minimally invasive adenocarcinoma and invasive adenocarcinoma less than or equal to 3 cm: A two-center retrospective study
View abstract on PubMed
Summary
This summary is machine-generated.A novel Radiological-Radiomics (R-R) combined model effectively differentiates minimal invasive adenocarcinoma (MIA) from invasive adenocarcinoma (IA) in lung adenocarcinoma (LUAD). This R-R model demonstrates excellent diagnostic performance, aiding clinical decisions and surgical planning for LUAD patients.
Area Of Science
- Oncology
- Radiology
- Medical Imaging
- Machine Learning in Medicine
Background
- Lung adenocarcinoma (LUAD) classification into minimal invasive adenocarcinoma (MIA) and invasive adenocarcinoma (IA) is crucial for treatment.
- Accurate differentiation between MIA and IA impacts patient prognosis and therapeutic strategies.
Purpose Of The Study
- To develop and evaluate a combined Radiological-Radiomics (R-R) model for distinguishing MIA from IA in LUAD.
- To assess the predictive performance of the R-R model using clinical, pathological, and imaging data.
Main Methods
- Retrospective analysis of 509 LUAD patients (522 lesions) from two medical centers.
- Feature selection using the Least Absolute Shrinkage and Selection Operator (LASSO) method.
- Development of Radiological, Radiomics, and R-R models using logistic regression; performance evaluated via ROC curves (AUC, sensitivity, specificity, accuracy).
Main Results
- The R-R model achieved high diagnostic performance across training, validation, and external test sets.
- In the external test set, the R-R model reported an AUC of 0.894, sensitivity of 84.8%, specificity of 78.6%, and accuracy of 83.3%.
- The R-R model demonstrated excellent diagnostic performance in differentiating MIA and IA.
Conclusions
- The developed R-R model exhibits excellent diagnostic performance for differentiating MIA and IA in LUAD.
- This model can serve as a valuable reference for clinical diagnosis and surgical treatment planning in LUAD management.

